Patient reported outcomes for intensified versus conventional NB-UVB treatment in non-segmental vitiligo

Figures & data

Table 1. Patient characteristics.

	Group I (conventional), N = 47	Group II (intensified), N = 45
Male:female ratio	1:1.8	1:1.1
Mean age ± SD (min–max)	43 ± 13 (17–68)	46 ± 14 (21–74)
Disease duration >5 years	66%	56%
Skin type
I	2%	4%
II	55%	64%
III	34%	11%
IV	4%	7%
V	4%	13%
VI	0%	0%

SD: standard deviation.

Table 2. Characteristics and results of treatment.

	Group I (conventional)	Group II (intensified)	p-value
Mean number of treatments per week	2.3	3.0	<.001*
Time investment per week in minutes, median [IQR]	20 [10–40]	25 [12–40]	.72
Missed – more than 10 treatments	13%	27%	.38
Suberythema – more than 20 times	40%	42%	.27
Painful erythema occurrence – more than 10 times	8.5%	4.4%	.79
Blistering	0%	4.4%	.14

* significant.

Figure 1. The onset of repigmentation per patient group. No significant differences were found between groups (Chi square test, p=.11).

Table 3. Median repigmentation (%) at different body sites at the end of therapy.

	Group 1 (conventional )	N	Group II (intensified)	N	p-value
	Median [IQR]		Median [IQR]
Face	60 [6–80]	28	75 [11–90]	40	0.20
Neck	40 [30–70]	19	50 [9–80]	25	0.79
Trunk	30 [10–55]	30	20 [6–50]	33	0.50
Arms	40 [10–60]	29	25 [6–60]	31	0.49
Hands	10 [0–30]	31	3 [0–30]	32	0.37
Legs	35 [6–58]	24	40 [6–70]	33	0.78
Feet	0 [0–15]	17	0 [0–5]	25	0.60

IQR: interquartile range.

Figure 2. Satisfaction with result after one year NB-UVB therapy per patient group. No significant differences were found between groups (Chi square test, p=.91).